Some of the most valuable things a company owns cannot be touched: a patent, a software platform, a licence, a customer database, a famous brand. Yet the statement of financial position often shows none of them. International Accounting Standard (IAS) 38, Intangible Assets, explains why.
It lets a company record an intangible only if it can identify it, control it, expect benefits from it and measure its cost reliably, and it bans some of the most tempting ones, such as internally built brands.
This topic covers the definition and attributes of an intangible asset, recognition, how intangibles are acquired, the research and development rules, intangibles acquired in a business combination, measurement after recognition (cost and revaluation models), amortisation and indefinite lives, and the judgements. The previous topics covered property, plant and equipment and investment property. The next topics cover provisions and impairment.
May 2026 Question 7(c) asked whether a valued brand name could be recorded as an asset.
In 30 seconds
An intangible asset is an identifiable, non-monetary asset without physical substance. It must be identifiable (separable, or arising from contractual or legal rights), controlled, and expected to bring future economic benefits. It is recognised at cost if the benefits are probable and the cost is reliably measurable. Internally generated goodwill, brands, mastheads, publishing titles and customer lists are never recognised.
For internally generated projects, research is expensed and development is capitalised only when six conditions are shown (technical feasibility, intention, ability to use or sell, future benefits, resources, reliable measurement), and expenditure already expensed cannot be reinstated. An intangible bought in a business combination is recognised at fair value, including in-process research and development. Afterwards use the cost model or, only where there is an active market, the revaluation model.
Finite-life intangibles are amortised. Indefinite-life intangibles are not amortised but tested for impairment every year.
Key terms in plain English
| Term | What it means |
|---|---|
| Intangible asset | An identifiable non-monetary asset with no physical form |
| Identifiable | Can be separated and sold or licensed, or arises from legal or contractual rights |
| Research | Original, planned investigation to gain new knowledge |
| Development | Applying research findings to a plan or design before commercial production starts |
| Active market | One where items are similar, buyers and sellers are always available and prices are public |
| Amortisation | Spreading the cost of an intangible over its useful life, like depreciation |
| Indefinite useful life | No foreseeable limit to the period over which the asset is expected to produce cash inflows |
Syllabus check
IAS 38 is examinable at this level. This topic covers:
- B2(a) the effect of recognition and measurement choices and timing on non-financial assets;
- B2(b) appraising the treatment of intangible assets under IAS 38;
- D1(d) appraising the nature and validity of items in published statements, which includes challenging an intangible that should not be there.
CAMA 2020 and intangible assets
The Companies and Allied Matters Act 2020 (CAMA 2020) sets the records and statements, not the intangible rules.
| Section | What it says | Link to IAS 38 |
|---|---|---|
| s. 374(1) | The company keeps accounting records that explain its transactions | Project costing records are what prove development costs are reliably measured |
| s. 377(1) and s. 378 | Directors prepare statements that follow International Financial Reporting Standards (IFRS) and give a true and fair view | Recording a banned intangible such as an internally built brand would breach the standard |
| s. 404(7) | The audit committee reviews accounting policies and internal control | It can challenge capitalisation decisions |
| s. 405 | The chief executive officer (CEO) and chief financial officer (CFO) of a company that is not a small company certify responsibility for internal controls | Controls over what is capitalised fall under this duty |
Definition and recognition
An intangible asset is an identifiable, non-monetary asset without physical substance. An asset is a resource controlled by the entity as a result of past events from which future economic benefits are expected. The critical attributes are:
- Identifiability: it is separable (can be sold, transferred, licensed, rented or exchanged, alone or with a contract, asset or liability) or arises from contractual or other legal rights.
- Control: the entity has the power to obtain the benefits and restrict others’ access.
- Future economic benefits: revenues or cost savings.
Examples: patented technology, software, databases, trademarks, domain names, films, customer lists (if acquired), licensing and franchise agreements, import quotas, marketing rights.
An intangible asset is recognised if, and only if, (i) it is probable that the expected future benefits will flow to the entity and (ii) the cost can be measured reliably, and it meets the definition. It is first measured at cost. Later expenditure is capitalised only if it can be attributed to the asset and enhances it, which is rare.
How intangibles are obtained
- Purchased separately: the probability test is always met, and cost is usually reliable.
- Acquired in an exchange: measured at fair value unless the exchange lacks commercial substance or neither fair value can be measured reliably, in which case at the carrying amount of the asset given up.
- Government grant: treated under IAS 20.
- Internally generated: see below.
- Acquired in a business combination: see below.
Internally generated intangibles
These items are never recognised: internally generated goodwill, brands, mastheads, publishing titles and customer lists, because their cost cannot be distinguished from the cost of developing the business as a whole.
For other internally generated intangibles, split the project into two phases:
- Research (original and planned investigation to gain new knowledge): expense.
- Development (applying research findings to a plan or design before commercial production): capitalise only if all of these are shown:
- it is technically feasible to complete the asset;
- the entity intends to complete it and use or sell it;
- the entity is able to use or sell it;
- it will generate probable future economic benefits (a market for the output or usefulness within the entity);
- adequate technical, financial and other resources are available to complete it; and
- the expenditure can be measured reliably.
Only expenditure after all the conditions are met can be capitalised. Expenditure already expensed cannot be reinstated as an asset later. If research and development cannot be separated, the whole is treated as research.
Intangibles acquired in a business combination
The acquirer recognises an identifiable intangible at fair value at the acquisition date, because the recognition criteria are taken as met. If the cost cannot be measured reliably, the item is included in goodwill. The acquirer also recognises the target’s in-process research and development if it meets the definition of an asset and is identifiable, even though the target expensed it.
Further spending on that project is treated under the normal rules: research is expensed, and development is capitalised only when the six conditions are met.
Measurement after recognition
- Cost model: cost less accumulated amortisation and impairment.
- Revaluation model: fair value at the revaluation date less later amortisation and impairment, allowed only if fair value can be found in an active market. Active markets for intangibles are rare, so very few entities revalue. The same model applies to the whole class.
Amortisation and useful life
The entity assesses whether the life is finite or indefinite. A finite-life asset is amortised systematically over its useful life from the date it is available for use, to the earlier of classification as held for sale and derecognition. Residual value is normally nil. An indefinite-life asset is not amortised, but is tested for impairment annually and whenever there is an indication of impairment.
The assessment of an indefinite life is reviewed each period, and a change to finite is a change in estimate. Goodwill acquired in a business combination is also tested annually and never amortised.
Areas of judgement
- Whether an internally generated asset meets the recognition criteria.
- Allocating the price in a business combination, including which intangibles to recognise.
- Cash flows and discount rates in impairment tests.
- Amortisation periods.
The rules in more depth
Why research is expensed and development capitalised
At the research stage, it is not yet clear that the work will produce anything. At the development stage, a specific product is near and the six conditions are evidence that it will pay off.
Why brands and customer lists cannot be recognised if built internally
The money spent on advertising or building a client base cannot be separated from the cost of the business as a whole, and a valuation is not a cost. A bought brand has a price paid and is recognised.
Why a valuation by a consultant does not help
Reliable measurement here means a reliable cost of an item that meets the definition. IAS 38 prohibits the item itself. A consultant’s valuation is an opinion of value, not a cost.
Why no amortisation does not mean no test
An asset with no foreseeable end to its benefits is not worn out year by year. But its value can fall suddenly, so the impairment test every year stands in for amortisation.
Worked examples
Example 1: a development project. A company spends ₦3 million on research, ₦2 million on development before it can show the six conditions, and ₦6 million on development after they are met. The product launches and the asset is available for use with a 5-year life, straight line, no residual value. The figures are illustrative.
- Expensed:
research ₦3m + development before criteria ₦2m = ₦5 million. - Capitalised: ₦6 million (only expenditure after the conditions were met). The ₦2m cannot be added later.
- Amortisation.
₦6m ÷ 5 = ₦1.2 million a year, from when the asset is available for use. - The costing records support the six conditions and the reliable measurement (s. 374(1) of CAMA 2020).
Example 2: patent acquired in a business combination. Beverages Plc buys 70% of Cocoa Plc. Cocoa has an unrecognised patent with a fair value of ₦6 million and four years left, not renewable.
- The patent is identifiable (a legal right), so the group recognises it at fair value, ₦6 million, even though Cocoa’s own statements do not.
- Amortisation = ₦6m ÷ 4 = ₦1.5 million a year.
After one year the carrying amount is ₦4.5m.
Example 3: in-process research and development. Company X buys 100% of Company Y. Y spent ₦600,000 on research and development and expensed it all. X values the know-how from the project at ₦500,000. After the acquisition Y spends a further ₦150,000, which does not meet the development criteria.
- In Y’s own statements nothing is recognised.
- In the group statements the know-how is recognised at fair value, ₦500,000.
- The further ₦150,000 is expensed, because it is research or development that does not meet the criteria.
Example 4: a valued brand. The managing director wants to record the company’s own brand at ₦250 million, a figure produced by a certified consultant after market research.
- IAS 38 prohibits recognising internally generated brands. A reliable valuation does not change that.
- The brand cannot be recorded. The cost of the valuation and the market research are expensed.
- Only a brand that is bought, separately or in a business combination, can be recognised, at its cost or fair value.
How to score full marks
- Test the definition first: identifiable, control, future benefits. Then the two recognition tests.
- Name how the asset arose: bought, exchanged, internally generated or from a business combination, because the rule differs.
- For internal projects, split research from development and list the six conditions. Recognise only from the date they are all met.
- For prohibited items, state the rule and say why a valuation does not help.
- For amortisation, say finite or indefinite, give the charge and, for indefinite life, state the annual impairment test.
- Remember business combinations: fair value, and in-process research and development.
Common mistakes in the exam
- Capitalising research costs.
- Capitalising development costs incurred before the conditions are met, or reinstating them later.
- Recognising an internally built brand, mastheads, publishing titles or customer lists.
- Amortising goodwill or an indefinite-life intangible.
- Revaluing intangibles without an active market.
- Forgetting that a business combination recognises intangibles the target never recorded.
- Treating the consultant’s valuation as proof that the asset can be recognised.
Quick revision
- Definition: identifiable, non-monetary, no physical substance. Attributes: identifiable, control, future benefits.
- Recognise at cost if probable benefits and reliable cost.
- Never recognise internally generated goodwill, brands, mastheads, publishing titles, customer lists.
- Research: expense. Development: capitalise only if six conditions are met, from that date.
- Business combination: fair value, including in-process research and development.
- Models: cost, or revaluation only with an active market.
- Finite: amortise. Indefinite: no amortisation, annual impairment test.
- CAMA 2020: ss. 374(1), 377(1), 378, 404(7), 405.
Practice questions
These are original questions written in the style of the Institute of Chartered Accountants of Nigeria (ICAN) exam. Try each one before you open the answer. Full model answers follow the written questions.
Recall check: multiple choice
The real ICAN paper has no multiple-choice section. These questions are for quick recall. The written questions that follow are closer to the exam.
Question 1. An intangible asset must be:
- Physical
- Identifiable, non-monetary and without physical substance
- Monetary
- Always internally built
Show the answer
B. It must also be controlled and expected to give benefits.
Question 2. Which of the following can never be recognised if internally generated?
- Development costs meeting all conditions
- A brand
- Software bought from a vendor
- A patent bought for cash
Show the answer
B. Also goodwill, mastheads, publishing titles and customer lists.
Question 3. Research costs are:
- Capitalised
- Expensed
- Deferred
- Revalued
Show the answer
B. Development can be capitalised if six conditions are shown.
Question 4. Development expenditure already expensed:
- Can be reinstated later as an asset
- Cannot be reinstated as an asset
- Must be doubled
- Is revenue
Show the answer
B. Only expenditure after the conditions are met is capitalised.
Question 5. An intangible asset acquired in a business combination is measured at:
- Zero
- Fair value at the acquisition date
- The target’s cost
- Tax value
Show the answer
B. If cost cannot be measured reliably it falls into goodwill.
Question 6. Revaluation of an intangible asset is allowed only if:
- The directors want it
- Fair value is determined by reference to an active market
- The auditor agrees
- It is a brand
Show the answer
B. Active markets for intangibles are rare.
Question 7. An intangible asset with an indefinite useful life is:
- Amortised over 20 years
- Not amortised but tested for impairment at least annually
- Expensed immediately
- Revalued annually
Show the answer
B. Goodwill is treated the same way.
Question 8. A patent costing ₦12m is amortised straight line over 6 years. Annual amortisation is:
- ₦2m
- ₦3m
- ₦4m
- ₦12m
Show the answer
A. ₦12m ÷ 6.
Question 9. A company spends ₦4m on research and ₦5m on development after meeting all the conditions. Amount capitalised is:
- ₦4m
- ₦5m
- ₦9m
- Nil
Show the answer
B. Research is expensed.
Question 10. Which section of CAMA 2020 requires the statements to follow IFRS and give a true and fair view?
- Section 378
- Section 394
- Section 402
- Section 409
Show the answer
A. IAS 38 is part of IFRS.
Written questions
Question 11 (10 marks). (a) Define an intangible asset and state its critical attributes. (4 marks) (b) State three items that cannot be recognised if internally generated. (3 marks) (c) Distinguish research from development and state their treatment. (3 marks)
Question 12 (20 marks). (a) State the conditions for capitalising development costs. (6 marks) (b) Explain how intangibles acquired in a business combination, including in-process research and development, are treated. (4 marks) (c) Explain the models after recognition and the treatment of finite and indefinite lives. (5 marks) (d) A company spends ₦3m on research, ₦2m on development before the conditions are met and ₦6m after.
The asset has a 5-year life. Calculate the amount expensed, the amount capitalised and the annual amortisation. (5 marks)
Question 13 (10 marks). The managing director of Fiwajoye Plc wants to record the company’s own brand as an asset at ₦250 million, a valuation by a certified consultant after market research. (a) State the relevant principle. (3 marks) (b) Apply it to the facts. (4 marks) (c) Conclude, and state the treatment of the valuation cost and of a brand that is acquired. (3 marks)
Model answers
Show the model answer to Question 11
(a) Definition (4 marks). An identifiable, non-monetary asset without physical substance. (1) Attributes: identifiable (separable, or from legal or contractual rights), (1) control, (1) and future economic benefits. (1)
(b) Prohibited (3 marks, any three at 1). Goodwill. Brands. Mastheads. Publishing titles. Customer lists.
(c) Research and development (3 marks). Research is original and planned investigation to gain new knowledge and is expensed. (1.5) Development applies research findings to a plan or design before commercial production and is capitalised only if the criteria are met. (1.5)
Show the model answer to Question 12
(a) Conditions (6 marks, 1 each). Technical feasibility of completion. Intention to complete and use or sell. Ability to use or sell. Probable future economic benefits, such as a market. Adequate resources to complete. Reliable measurement of expenditure. (Only expenditure after all are met is capitalised, and expensed amounts cannot be reinstated.)
(b) Business combination (4 marks). An identifiable intangible is recognised at fair value at the acquisition date. (1.5) If cost cannot be measured reliably it is included in goodwill. (0.5) In-process research and development is recognised if it meets the definition of an asset and is identifiable, even if the target expensed it. (1.5) Later spending follows the normal rules. (0.5)
(c) Models and lives (5 marks). Cost model: cost less amortisation and impairment. (1) Revaluation model: only if fair value is determined in an active market, which is rare. (1.5) Finite life: amortise systematically from when available for use. (1) Indefinite life: do not amortise, test for impairment at least annually, and review the assessment each period. (1.5)
(d) Calculation (5 marks).
- Expensed = ₦3m + ₦2m = ₦5m. (2)
- Capitalised = ₦6m. (2)
- Amortisation = ₦6m ÷ 5 = ₦1.2m a year. (1)
Show the model answer to Question 13
(a) Principle (3 marks). IAS 38 prohibits recognising internally generated brands, mastheads, publishing titles and customer lists, because the expenditure cannot be distinguished from the cost of developing the business as a whole. (3)
(b) Application (4 marks). The brand has been built internally over time. (1) The consultant’s valuation and market research do not override the prohibition. (2) A reliable valuation is not enough for recognition, because the item itself is barred and a valuation is not a cost. (1)
(c) Conclusion (3 marks). The proposal should be rejected and the brand not recognised. (1) The valuation and research costs are expensed as incurred. (1) Only a brand that is acquired, separately or in a business combination, may be recognised, at cost or fair value. (1)
Pathfinder on IAS 38 intangible assets
These are the ICAN Pathfinder questions that test this topic. ICAN owns the questions and the suggested solutions, so we point you to them and do not copy them. Open your Pathfinder, attempt each question under exam conditions, then check your answer against the notes above.
The marking guide gives 1 mark each for the facts, the applicable standard, its application, the accounting treatment and the conclusion. The solution says IAS 38 prohibits internally generated brands, a certified valuation does not overcome it, the valuation and research costs are expensed and only an acquired brand can be recognised. Worked example 4 and practice question 13 follow that answer.
Revise first: Internally generated intangibles
The solution recognises the unrecorded patent at its fair value of ₦6 million, amortises it over four years (₦1.5 million a year) and includes it in the fair value adjustments. Worked example 2 uses the same figures.
Revise first: Intangibles acquired in a business combination
Source: ICAN Pathfinder, Strategic Business Reporting. Diets covered: May Diet, 2026 and November Diet, 2025.
Spotted a mistake? Tell us and we will check it.